Abagon, Keith Ezekiel M.
HRN: 12-64-48 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2022
CEFUROXIME 750MG (VIAL)
05/05/2022
05/11/2022
IVTT
540 Mg
Q8
Leucocytosis, ARTI
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes